State of New Jersey Common Pension Fund D’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$459K Buy
24,996
+2,727
+12% +$43.9K ﹤0.01% 1636
2026
Q1
$436K Buy
22,269
+28
+0.1% +$832 ﹤0.01% 1471
2025
Q4
$692K Buy
+22,241
New +$610K ﹤0.01% 1420

Other funds holding VRDN

State of New Jersey Common Pension Fund D's VRDN Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D increased its Viridian Therapeutics (VRDN) stake by 12% in Q2 2026, buying an estimated $43.9K and bringing the position to 24,996 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #1636.

State of New Jersey Common Pension Fund D first reported a position in VRDN in Q4 2025 and has held it in 3 quarters since. The position peaked at $692K in Q4 2025. 52 funds tracked by Wall St. Rank hold VRDN as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 24,996 shares of Viridian Therapeutics worth $459K as of Q2 2026.
  • State of New Jersey Common Pension Fund D bought 2,727 Viridian Therapeutics shares in Q2 2026, an estimated $43.9K.
  • Viridian Therapeutics made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1636 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Viridian Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • State of New Jersey Common Pension Fund D's Viridian Therapeutics position peaked at $692K in Q4 2025.
  • 52 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.